Risk of ocular hypertension in children treated with systemic glucocorticoid

Susanne Krag1, Dorte Larsen1, Birgitte Klug Albertsen2

  • 1Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark.

Acta Ophthalmologica
|February 25, 2021
PubMed

Insights

Systemic glucocorticoid treatment in children can cause ocular hypertension. Monitoring intraocular pressure is recommended, as younger children may face a higher risk of steroid-induced eye pressure increases.

Area of Science:

  • Pediatric Ophthalmology
  • Endocrinology
  • Pharmacology

Background:

  • Systemic glucocorticoids are widely used in pediatric care.
  • Potential side effects include ocular hypertension, a condition characterized by elevated intraocular pressure.
  • Understanding this risk is crucial for patient safety and monitoring.

Purpose of the Study:

  • To investigate the incidence and characteristics of steroid-induced ocular hypertension in children receiving systemic glucocorticoid therapy.
  • To identify potential risk factors associated with this adverse effect.

Main Methods:

  • A prospective cohort study involving children treated with high-dose systemic glucocorticoids (>0.5 mg/kg/day prednisolone equivalent) for over two weeks.
  • Intraocular pressure (IOP) was measured using an Icare tonometer.
  • Ocular hypertensive response defined as a net increase in IOP ≥6 mmHg or peak IOP ≥21 mmHg.

Main Results:

  • 56% of the 16 children studied developed a steroid-induced ocular hypertensive response.
  • 12% were classified as high responders with significant IOP elevations.
  • Younger children were more likely to be steroid responders (p=0.03).
  • No correlation found between IOP increase and steroid dosage or duration.

Conclusions:

  • Systemic glucocorticoid therapy in children poses a significant risk of elevated intraocular pressure.
  • Regular intraocular pressure screening is essential for children undergoing such treatments.
  • Age appears to be a significant factor, with younger children being more susceptible; further research into ethnic variations is warranted.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
822
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
949
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.3K
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
2.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
191